PMRA FORMFORM 8 ADVT
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
FORM 8 ADVT is the official PMRA identifier for “Application for advertisement of medicine or allied substance”. FORM 8 ADVT is the official identifier PMRA uses for this instrument.
- Instrument
- FORM
- Full name
- FORM 8 ADVT
- Category
- Labeling
- Source publication
- English
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Application for advertisement of medicine or allied substance
Complete two-page PMRA Form 8 ADVT, including all applicant, proposed activity, two material samples, product, language, target-audience, signature and office-receipt fields. Both unchanged original page images are retained, including the printed (6)-before-(5) field order. The form expressly names medicine or allied substance; the 2019 Act includes devices within allied substances. The form alone does not establish a complete device advertising or change-approval procedure, fee, processing deadline or current mandatory form version. A separately retrieved 2026-uploaded Word form has the same field families but no controlled issue date; upload dates do not establish legal replacement. The five-page August 2020 advertising guidance has a narrower express scope of conventional medicines, traditional medicinal products and food supplements; its fourteen-day advertising response must not be repurposed as a device variation deadline. This undated original remains currentness-unverified and excluded from default current discovery pending product-specific and later-version reconciliation.
FORM 8 ADVT is the official identifier PMRA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.